UNSPSC 51351513: Pregnenolone

This classification denotes a therapeutic progestin with the molecular formula C21H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 73R90F7MQ8, chemically known as 17.alpha.-pregn-5-en-20-one, 3.beta.-hydroxy- but generally known as pregnenolone, which bears US NIH Compound Identifier 1027. European Medicines Agency schedules Pregnenolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10024MIG. The term PREGNENOLONE is an International Non-Proprietary Name.

UNSPSC 51351513 Pregnenolone, a Commodity code, appears in state and local procurement activity focused on pharmaceutical procurement and laboratory supply sourcing. The code identifies a specific steroid precursor compound used in medical testing, research, and diagnostic applications within state health departments, county health systems, and public health laboratories. State and local buyers under this code typically source pregnenolone for clinical laboratory analysis, hormone-level testing, and research support functions within public health infrastructure.

The source provided contains no recent state and local contract opportunities tagged to this code, limiting visibility into current issuing-body concentration, geographic spread, or representative solicitations. Without posted RFP, RFQ, IFB, or ITB activity in the dataset, the code's current market activity cannot be characterized from available procurement records.